secwatch.observer — SEC 8-K summary
======================================

Issuer:     BNB PLUS CORP. (BNBX)
CIK:        0000744452
Form:       8-K
Filed at:   2024-05-10T23:59:59+00:00
Accession:  0001104659-24-059893
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Applied DNA Q2 revenue down 79% to $930k; operating loss widens to $3.6M
------------------------------------------------------------------------

- Total revenue $930k vs $4.4M YoY; COVID testing contract with CUNY ended June 2023.
- Gross profit declined to $296k (32% margin) from $1.8M (41%) YoY.
- Operating loss $3.6M vs $2.7M YoY; adjusted EBITDA -$3.3M.
- Cash $3.1M as of March 31, 2024, down from $7.2M at Sept 30, 2023.
- Effected 1-for-20 reverse stock split on April 25, 2024; regained Nasdaq bid price compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/744452/000110465924059893/0001104659-24-059893-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/744452/000110465924059893/tm2414131d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-059893

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer